VT02956 |
| Catalog No.GC70131 |
VT02956는 LATS 억제제입니다 (IC50: LATS1은 0.76 nM, LATS2는 0.52 nM). VT02956은 Hippo 신호 경로를 타겟으로 합니다. VT02956은 ER+ 유방암 세포주 및 환자 샘플에서 종양류 장기의 성장과 ESR1 발현을 억제합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for VT02956
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for VT02956
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *